openPR Logo
Press release

Antihypertensive Drugs Market Segments, Leading Player, Application and Forecast Analysis

07-28-2022 01:18 PM CET | Health & Medicine

Press release from: Transparency Market Research

Antihypertensive Drugs Market Outlook 2031

• The global antihypertensive drugs market was valued at US$ 30.2 Bn in 2021
• The global market is projected to grow at a CAGR of 3.0% from 2022 to 2031
• The global antihypertensive drugs market is anticipated to reach more than US$ 40 Bn by the end of 2031

Analysts' Viewpoint on Antihypertensive Drugs Market Scenario

Increase in launch of new drugs and diagnostic agents; and key industry developments such as collaborations and establishment of new R&D centers are likely to propel the global antihypertensive drugs market. In 2017, Abbott Laboratories opened a new China R&D center to meet the evolving healthcare needs of local consumers in Shanghai. Daiichi Sankyo collaborated with the University of California San Francisco's Institute for Neurodegenerative Diseases for joint research and development of drugs and diagnostic agents for various neurodegenerative diseases. Rise in disposable income and launch of new disease-modifying therapies are projected to propel the global antihypertensive drugs market during the forecast period. Significant growth in telemedicine and e-Health apps is also likely to create long-term revenue opportunities for companies in the antihypertensive drugs market.

Read Report Overview- https://www.transparencymarketresearch.com/antihypertensive-drugs-market.html

Overview of Antihypertensive Drugs Market

Antihypertensive medications are used to treat high blood pressure. Different types of antihypertensive drugs are available in the market. These help lower blood pressure. Some remove excess fluid and salt from the body, while others help relax and widen blood vessels or slow the heart rate. A person could respond better and experience fewer side effects to one drug than to another. Some patients require more than one antihypertensive agent to lower blood pressure.
Hypertension is a preventable risk factor for atherosclerotic disease and ischemic heart disease. A number of patients maintain suboptimal blood pressure control despite the availability of modern and effective antihypertensive drugs. Most hypertensive patients require a combination of antihypertensive agents to achieve treatment goals. Under combination therapy, another class of blood pressure medication is added to the first drug to increase its effectiveness. The antihypertensive drugs market has reasonably high unmet demand, which indicates the lack of effective products. This presents significant opportunities for new entrants to capitalize on the unmet needs, largely due to poor patient compliance with products currently available in the market.

Request a Sample of Antihypertensive Drugs Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7718

Trends in antihypertensive medication in stroke survivors could provide important insights into gaps in secondary prevention that can guide improved interventions in the future. Healthcare companies are increasing R&D in the field of genomics and resistant hypertension treatment to gain a competitive edge over other market players.

Enquiry before Buying Antihypertensive Drugs Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=7718

Launch of New Disease-modifying Therapies to Drive Global Antihypertensive Drugs Market

Innovative antihypertensive drugs and drug therapies are expected to offer favorable outcomes, as these effectively target disease progression. The current scenario in the global antihypertensive drugs market is expected to change due to the launch of new therapies for diseases such as angiotensin II receptor blockers (ARBs), angiotensin converting enzyme (ACE) inhibitors, and calcium channel blockers (CCB) during the forecast period.

Currently, physicians prescribe fewer diuretics and beta-blockers, common first-line agents for hypertension, and more ACE and CHF inhibitors. ACE inhibitors reduce mortality and morbidity in cardiovascular patients; however, this is not true for CCBs. If control is not available on beta-blockers, diuretics, or ACE inhibitors, short-acting CHFs should be avoided and alternatives should be considered. Unlike ACE inhibitors, ARBs do not cause cough. Therefore, launch of innovative drug/therapeutic molecules with disease-modifying properties and improved efficacy and safety is expected to drive the global antihypertensive drugs market in the next few years.

More Trending Reports by Transparency Market Research:

Alpha 1 Antitrypsin Deficiency Treatment Market- https://www.transparencymarketresearch.com/alpha-1-antitrypsin-deficiency-treatment-market.html

Sterilization Equipment and Disinfectant Market- https://www.transparencymarketresearch.com/sterilization-equipment-market.html

Wound Debridement Market- https://www.transparencymarketresearch.com/wound-debridement-market.html

Ophthalmic Drugs Market- https://www.transparencymarketresearch.com/ophthalmic-drugs-market.html

Topical Pain Management Therapeutics in Sports Medicine Market- https://www.transparencymarketresearch.com/topical-pain-management-therapeutics-sports-medicine-market.html

Respiratory Disorders Treatment Market- https://www.transparencymarketresearch.com/respiratory-disorders-treatment-market.html

Cryptococcosis Market- https://www.transparencymarketresearch.com/cryptococcosis-market.html

Non-alcoholic Steatohepatitis (NASH) Biomarkers Market- https://www.transparencymarketresearch.com/non-alcoholic-steatohepatitis-biomarkers-market.html

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antihypertensive Drugs Market Segments, Leading Player, Application and Forecast Analysis here

News-ID: 2692629 • Views:

More Releases from Transparency Market Research

Autoinjectors Market Size & Share to Surpass USD 3.8 Bn by 2031, at a CAGR 16.2% - Transparency Market Research, Inc.
Autoinjectors Market Size & Share to Surpass USD 3.8 Bn by 2031, at a CAGR 16.2% …
Autoinjectors have emerged as a pivotal innovation in the medical device industry, offering a convenient and efficient means of administering injectable medications. These devices are designed to improve patient compliance, enhance the ease of medication administration, and provide timely treatment in emergency situations. As the global demand for autoinjectors grows, driven by increasing prevalence of chronic diseases and advancements in technology, the market for these devices is expanding rapidly. This
Onco-hematology Molecular Testing Market Size to Hit USD 1.5 Bn by 2031, at a 12.5% CAGR | Analysis by Transparency Market Research, Inc.
Onco-hematology Molecular Testing Market Size to Hit USD 1.5 Bn by 2031, at a 12 …
Onco-hematology molecular testing is a rapidly evolving field dedicated to the detection, diagnosis, and monitoring of blood cancers through advanced molecular techniques. As the understanding of blood malignancies deepens, so does the need for precise and effective diagnostic tools. The onco-hematology molecular testing market is experiencing significant growth, driven by advancements in molecular biology, increasing incidence of blood cancers, and the demand for personalized medicine. This blog post delves into
Laboratory Consumables Market to Attain USD 301.2 Bn with a 5.1% CAGR by 2031, Reports by Transparency Market Research, Inc.
Laboratory Consumables Market to Attain USD 301.2 Bn with a 5.1% CAGR by 2031, R …
The laboratory consumables market plays a crucial role in the functioning of laboratories across various sectors, including healthcare, pharmaceuticals, biotechnology, and research. These consumables are essential for conducting experiments, diagnostics, and research, ranging from reagents and kits to general lab supplies. As the global demand for advanced scientific research and diagnostic services grows, the laboratory consumables market is expanding rapidly. This blog post provides a comprehensive overview of the laboratory
Cancer Biopsy Market on Track to Attain USD 66.0 Bn by 2031, Fueled by a 11.4% CAGR | Exclusive Report by Transparency Market Research, Inc.
Cancer Biopsy Market on Track to Attain USD 66.0 Bn by 2031, Fueled by a 11.4% C …
Cancer biopsy is a critical diagnostic tool in the management and treatment of cancer. It involves the removal of a sample of tissue from a patient, which is then examined for the presence of cancerous cells. The cancer biopsy market has been experiencing substantial growth due to advancements in technology, increasing cancer incidence, and the rising demand for precise diagnostic methods. This blog post delves into the current state of

All 5 Releases


More Releases for Antihypertensive

Global Antihypertensive Drugs Market Study Analysis: Hypertension is becoming ev …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 4.87% during the forecast period. Hypertension is a medical condition that results in a rise in blood pressure in the arteries. Hypertension may lead to numerous serious complications including heart failure, aneurysm, heart attacks, and dementia. To prevent the serious effects of hypertension early diagnosis
Antihypertensive Drugs Market Report 2021-2031 : Newly Published By Visiongain.
Forecasts By Drug (Diuretics, Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Beta-blockers, Vasodilators, Calcium Channel Blockers, Renin Inhibitors, Alpha-blockers and Others), By Condition (Primary Hypertension and Secondary Hypertension), By Medication type (Monotherapy, Combination Therapy and Fixed Dose Combinations), By Drug Type (Generic Drugs and Branded Drugs), By Patient Demographics (Geriatric Patient, Adult Patient and Pediatric), By End-User (Hospitals, Homecare, Specialty Clinics and Others), By Distribution Channel (Hospital Pharmacy, Retail pharmacy,
Antihypertensive Drugs Market Growth, Industry Analysis, Trends and Forecast - 2 …
Antihypertensive Market accounted for $22,557 million in 2018, and is expected to reach $28,797 million by 2025, registering a CAGR of 3% from 2019 to 2025. Antihypertensive drugs are used in the treatment of hypertensive patients. High blood pressure is a medical condition that involves elevated blood pressure in the arteries. Additionally, patients suffering from high blood pressure are very susceptible to other complications such as heart failure and aneurysms. Therefore,
Safety And Effectiveness Of First-line Antihypertensive Drug Classes
For those with extremely high blood pressure, or hypertension, there are many initial medication options -- so many that it can be hard to know which one to use. Now, a Yale-coauthored paper in Lancet provides more information about the relative safety and effectiveness of different hypertension drugs in order to inform this critical treatment decision. The study reveals that angiotensin converting enzyme (ACE) inhibitors may not be the best
Antihypertensive Drugs Market Growth and Forecast 2015 - 2023
Human health is being affected by various factors which include rapid urbanization, demographic ageing and the globalization of unhealthy lifestyles. Hypertension is one of the keyhealth issuesthat are observed in both developed as well as developing countries. It is a silent, invisible killer that rarely causes symptoms and is one of the key risk factors forcoronary heart disease and ischemic as well as hemorrhagic stroke. Hypertension can also lead to
Antihypertensive Drugs Market : Opportunities and Forecasts upto 2023
Human health is being affected by various factors which include rapid urbanization, demographic ageing and the globalization of unhealthy lifestyles. Hypertension is one of the keyhealth issuesthat are observed in both developed as well as developing countries. It is a silent, invisible killer that rarely causes symptoms and is one of the key risk factors forcoronary heart disease and ischemic as well as hemorrhagic stroke. Hypertension can also lead to